For over three decades, UCSF has had a Graduate Program in Pharmaceutical Chemistry (PC). This widely recognized and highly successful program has supplied a legion of outstanding scientists to the academic and industrial research community. For over two decades the program has been supported by the NIH training grant in Pharmaceutical Chemistry and Biopharmaceutical Sciences. The current application is a competitive renewal of this training grant. The application has been re-titled to Pharmaceutical Sciences and Pharmacogenomics (PSPG) to reflect the evolution of the training program in response to exciting scientific developments in the area of genomics that have far-reaching implications to the pharmaceutical and pharmacological sciences. The PSPG Graduate Program is a cross-disciplinary program that represents the merger at UCSF of scientists working in pharmaceutical sciences and contemporary genetics. This program broadly encompasses the areas of molecular pharmacology related to drug action, drug transport, drug metabolism and drug/gene delivery. The Program also includes the areas of kinetic/dynamic modeling, pharmacogenomics and bioinformatics applied to pharmacogenomics. The program offers in-depth training in these areas through a core curriculum that also encourages breadth of knowledge about these fields. In the past integrative approach has resulted in Ph.D. graduates who have the interdisciplinary insights and quantitative scientific tools that are characteristic of excellent scientists. Consequently our graduates are in high demand in academia, industry and government. With the identification and mapping of nearly 100,000 genes through the Human Genome Project, it is anticipated that there will be a major impact on diagnosis and treatment of human disease. There is enormous excitement in the pharmaceutical sciences and in human genetics, as people in each of these historically separate areas realize that understanding genetic contributions to drug response is an exciting frontier for both groups. Our program is one of the very few in the World with faculty expertise that spans these fields hence we believe the training program is ideally situated to provide the future scientific leaders in these scientific areas.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
2T32GM007175-26
Application #
6409838
Study Section
National Institute of General Medical Sciences Initial Review Group (BRT)
Program Officer
Preusch, Peter C
Project Start
1982-07-01
Project End
2007-06-30
Budget Start
2002-07-01
Budget End
2003-06-30
Support Year
26
Fiscal Year
2002
Total Cost
$151,677
Indirect Cost
Name
University of California San Francisco
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Ivry, Sam L; Meyer, Nicole O; Winter, Michael B et al. (2018) Global substrate specificity profiling of post-translational modifying enzymes. Protein Sci 27:584-594
Benet, Leslie Z; Bowman, Christine M; Liu, Shufang et al. (2018) The Extended Clearance Concept Following Oral and Intravenous Dosing: Theory and Critical Analyses. Pharm Res 35:242
Park, Danny S; Eskin, Itamar; Kang, Eun Yong et al. (2018) An ancestry-based approach for detecting interactions. Genet Epidemiol 42:49-63
Bielski, Craig M; Zehir, Ahmet; Penson, Alexander V et al. (2018) Genome doubling shapes the evolution and prognosis of advanced cancers. Nat Genet 50:1189-1195
Chang, Matthew T; Bhattarai, Tripti Shrestha; Schram, Alison M et al. (2018) Accelerating Discovery of Functional Mutant Alleles in Cancer. Cancer Discov 8:174-183
Theofilas, Panos; Ehrenberg, Alexander J; Nguy, Austin et al. (2018) Probing the correlation of neuronal loss, neurofibrillary tangles, and cell death markers across the Alzheimer's disease Braak stages: a quantitative study in humans. Neurobiol Aging 61:1-12
Trang, Tracy P; Whalen, Meghan; Hilts-Horeczko, Alexandra et al. (2018) Comparative effectiveness of aerosolized versus oral ribavirin for the treatment of respiratory syncytial virus infections: A single-center retrospective cohort study and review of the literature. Transpl Infect Dis 20:e12844
Gao, Yijun; Chang, Matthew T; McKay, Daniel et al. (2018) Allele-Specific Mechanisms of Activation of MEK1 Mutants Determine Their Properties. Cancer Discov 8:648-661
Ali, Ibraheem; Conrad, Ryan J; Verdin, Eric et al. (2018) Lysine Acetylation Goes Global: From Epigenetics to Metabolism and Therapeutics. Chem Rev 118:1216-1252
Dolor, Aaron; Szoka Jr, Francis C (2018) Digesting a Path Forward: The Utility of Collagenase Tumor Treatment for Improved Drug Delivery. Mol Pharm 15:2069-2083

Showing the most recent 10 out of 193 publications